ABIONYX Pharma SA (EPA:ABNX)
France flag France · Delayed Price · Currency is EUR
1.222
-0.016 (-1.29%)
May 6, 2025, 4:57 PM CET

ABIONYX Pharma Cash Flow Statement

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Net Income
-4.38-3.52-4.21-5.82-1.89
Upgrade
Depreciation & Amortization
0.50.140.120.120.02
Upgrade
Other Amortization
0.010.010.010-
Upgrade
Stock-Based Compensation
0.630.020.510.820.1
Upgrade
Other Operating Activities
-0.36-0.890.11-0.06-0.96
Upgrade
Change in Accounts Receivable
-0.080.380.04-0.1-
Upgrade
Change in Inventory
0.04-0.080.030.01-
Upgrade
Change in Other Net Operating Assets
0.020.230.03-1.662.13
Upgrade
Operating Cash Flow
-3.63-3.7-3.36-6.69-0.6
Upgrade
Capital Expenditures
-0.07-0.1-0.17-0.17-0.1
Upgrade
Sale of Property, Plant & Equipment
---00.02
Upgrade
Divestitures
---1.5-
Upgrade
Sale (Purchase) of Intangibles
-0.01-0.03-0.01--0.05
Upgrade
Investing Cash Flow
-0.08-0.13-0.181.34-0.13
Upgrade
Long-Term Debt Repaid
-0.49-0.3-0.24-0.02-0.2
Upgrade
Net Debt Issued (Repaid)
-0.49-0.3-0.24-0.02-0.2
Upgrade
Issuance of Common Stock
3.364.190.044.061.84
Upgrade
Repurchase of Common Stock
-0.02----
Upgrade
Other Financing Activities
----0.07-0.09
Upgrade
Financing Cash Flow
2.843.89-0.193.971.55
Upgrade
Miscellaneous Cash Flow Adjustments
-0----
Upgrade
Net Cash Flow
-0.870.06-3.73-1.380.82
Upgrade
Free Cash Flow
-3.7-3.8-3.52-6.86-0.7
Upgrade
Free Cash Flow Margin
-81.34%-81.94%-67.10%-1016.00%-
Upgrade
Free Cash Flow Per Share
-0.11-0.13-0.13-0.28-0.03
Upgrade
Levered Free Cash Flow
-1.85-2.47-2.06-5.040.3
Upgrade
Unlevered Free Cash Flow
-1.82-2.46-2.02-5.030.3
Upgrade
Change in Net Working Capital
0.090.37-0.082.08-2.18
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.